在严重喘中定义对生物治疗的反应:从全球评估到超级反应和缓解
Andriana I Papaioannou1, Evangelia Fouka2,3, Konstantinos Bartziokas4
11st Respiratory Medicine Department, National and Kapodistrian University of Athens, Medical School, "Sotiria" Chest Hospital, Athens, Greece.
Expert review of respiratory medicine
|June 15, 2023
概括
针对严重喘的单克隆抗体显示出不同患者的反应. 本综述澄清了治疗反应的定义和预测因素,有助于个性化严重喘管理.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重喘治疗越来越多地利用针对2型炎症的单克隆抗体.
- 尽管有患者选择,但个体对这些生物制剂的反应有很大差异.
研究的目的:
- 审查在严重喘中对生物药物的治疗反应的不断变化的定义.
- 识别反应的预测因素,包括超级响应者.
- 讨论喘缓解并提供评估算法.
主要方法:
- 关于严重喘中生物治疗反应的当前医学出版物的文献综述.
- 对评估各种响应指标 (恶化,症状,生活质量等) 的研究进行分析. ) 的情况.
- 预测因素的讨论和喘缓解的概念.
主要成果:
- 没有统一的治疗反应定义存在,创造了未满足的患者分层的需求.
- 识别响应者和不响应者对于优化生物疗法至关重要.
- 响应的预测者,包括超级响应者,正在被调查.
结论:
- 清晰的治疗反应定义对于有效的严重喘管理至关重要.
- 识别不响应者是切换或调整生物疗法的关键.
- 喘缓解正在成为潜在的治疗目标,得到响应评估算法的支持.
相关概念视频
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Drugs Used in Lower Respiratory Disorders: Overview
506
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
506
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
357
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
357
Asthma-IV: Nursing Management
3.2K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.2K
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K


